About Plasmagen Biosciences Private Limited
Data last updated:
Plasmagen Biosciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 07 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2010PTC055077. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹114.85 Cr and a paid-up capital of ₹114.34 Cr. It is led by directors including Vinod Nahar (Managing Director) and Robert Mark Weisskoff.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 160 Kci Chambers 2nd Floor 5th Main Road Chamarajpet, Bangalore, Karnataka, India – 560018.
As per the financials filed for FY 2025, the company reported a revenue of ₹161.85 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹97.09 Cr (net margin -60%) and EBITDA of -₹44.47 Cr (EBITDA margin -27.5%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 7% over five years.
The company has about 262 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: PlasmaGen BioSciences. As per MCA filings, the company has open charges of ₹305.25 Cr and satisfied charges of ₹20.55 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it. The company has 21 deals on record (9 funding rounds, 9 secondary share transfers, 1 debt financing), with disclosed funding of ₹648.89 Cr; the latest was in December 2025. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 334 overdue payments to 36 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website plasmagen.in.
Company details
Contact details
Plasmagen Biosciences Private Limited's registered office is in Bangalore, Karnataka. Its website is plasmagen.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo. 160 Kci Chambers 2nd Floor 5th Main Road Chamarajpet, Bangalore, Karnataka, India – 560018
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Plasmagen Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Plasmagen Biosciences operates one associated brand: PlasmaGen BioSciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Plasma-derived biopharmaceuticals including albumin and immunoglobulins are developed. | plasmagen.com |
Business activity
The main business activity of Plasmagen Biosciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Plasmagen Biosciences Private Limited, buy the company report.
Financials of Plasmagen Biosciences Private Limited
FY 2025 filings availablePlasmagen Biosciences Private Limited reported revenue of ₹161.85 Cr (up 1558% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹44.47 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹97.09 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -27.5% | ||||
| Net Profit Margin | -60% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Plasmagen Biosciences Private Limited, buy the company report.
Board of directors of Plasmagen Biosciences Private Limited
Plasmagen Biosciences has 5 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Robert Mark Weisskoff | Director | 28 Jul 2017 | 9 Years 3 Months | Current |
| Prem Venkatachalam Pavoor Also directs: Laurus Bio Private Limited, Immuneel Therapeutics Private Limited, Enzene Biosciences Limited and 3 more | Director | 28 Jul 2017 | 9 Years 3 Months | Current |
| Gopal Sarda Also directs: Wiz Plast Private Limited, Unnati Plastics Private Limited | Director | 07 Jul 2017 | 9 Years 3 Months | Current |
| Rahul Jain Also directs: Verogen Healthcare Private Limited | Director | 07 Jul 2017 | 9 Years 3 Months | Current |
| Vinod Nahar | Managing Director | 07 Sep 2010 | 16 Years 1 Months | Current |
Auditor
Plasmagen Biosciences Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2023 | 012754N/N500016 |
Shareholding
The shareholding of Plasmagen Biosciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Plasmagen Biosciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jun 2025 | 101115155 | Hdfc Bank Limited | ₹30 Cr | Open | |
| 29 Mar 2025 | 101128994 | Others | ₹30 Cr | Open | |
| 06 Sep 2024 | 100970548 | Sbicap Trustee Company Limited | ₹45 Cr | Open | |
| 22 Jun 2022 | 100591660 | Hdfc Bank Limited | ₹20 Cr | Open | |
| 31 Mar 2022 | 100564125 | Others | ₹25.24 Lakh | Open |
To see the full charge records of Plasmagen Biosciences Private Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Plasmagen Biosciences Private Limited has 21 deals on record (9 funding rounds, 9 secondary share transfers, 1 debt financing), with disclosed funding of ₹648.89 Cr; the latest was in December 2025.
Deals on record (5 of 21)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2025 | Funding round · Series F | ₹150.37 Cr | Investors: Vins Bioproducts Limited , Artian Investments, 2 individuals |
| Dec 2023 | Funding round · Series D | ₹120.8 Cr | Investors: Artian Investments, Eight Roads Ventures, 2 individuals |
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: Eight Roads Ventures Seller: Trigenesis Lifesciences Private Limited |
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: Eight Roads Ventures, 2 individuals Seller: Trigenesis Lifesciences Private Limited , 3 individuals |
| Aug 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: R S M Pharma Private Limited |
To see the full deal history of Plasmagen Biosciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Plasmagen Biosciences Private Limited has 3 court cases on record: 2 filed by Plasmagen Biosciences, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Revision petition | Filed against the company by an individual | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Govt. of NCT of Delhi & Ors. | Disposed |
| High Court of Delhi | Court case (CONT.CAS(C)) | Filed by the company against an individual | Disposed |
To see the full case history of Plasmagen Biosciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Plasmagen Biosciences Private Limited was last rated by Care on 07 Apr 2026.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 07 Apr 2026 |
To see the full credit ratings and regulatory alerts of Plasmagen Biosciences Private Limited, buy the company report.
MSME payment delays
Plasmagen Biosciences Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 334 overdue payments to 36 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 36)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Invitro Sciences | |||
| an individual supplier | |||
| Bioinvent | |||
| Spec & Cal Gases Private Limited | |||
| Sahasra Sai Cargo Services |
To see the full MSME payment records of Plasmagen Biosciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Plasmagen Biosciences Private Limited has a workforce of 262 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Plasmagen Biosciences has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Plasmagen Biosciences Private Limited, buy the company report.
Recent activity
Plasmagen Biosciences Private Limited has 16 board changes on record since 2010: 5 appointments and 11 cessations. The latest: Prem Venkatachalam Pavoor was appointed as Director on 28 Jul 2017.
23 earlier events are in the company report.
News
Frequently asked questions
Plasmagen Biosciences is an active private limited company based in Bangalore, Karnataka, India. The company works in wholesale, within the trading industry. It was incorporated on 07 September 2010 (16+ years old) and is registered under CIN U51909KA2010PTC055077.
Plasmagen Biosciences has 5 current directors:
- Vinod Nahar - Managing Director
- Robert Mark Weisskoff - Director
- Prem Venkatachalam Pavoor - Director
- Gopal Sarda - Director
- Rahul Jain - Director
The latest financial statements of Plasmagen Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Plasmagen Biosciences has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Plasmagen Biosciences is U51909KA2010PTC055077. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Plasmagen Biosciences has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the high courts.
Plasmagen Biosciences was incorporated on 07 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Bangalore.
Plasmagen Biosciences has 21 deals on record (9 funding rounds, 9 secondary share transfers, 1 debt financing), with disclosed funding of ₹648.89 Cr; the latest was in December 2025.
Prem Venkatachalam Pavoor was appointed as Director on 28 Jul 2017. Prem Venkatachalam Pavoor ceased to be Additional Director on 28 Jul 2017. Robert Mark Weisskoff was appointed as Director on 28 Jul 2017. Plasmagen Biosciences has 16 board changes on record in total.
Plasmagen Biosciences has 14 MSME Form 1 returns on record between 2019 and 2024, listing 334 overdue payments to 36 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Plasmagen Biosciences can be reached through the website plasmagen.in. Its registered office is in Bangalore, Karnataka, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
